as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹755.35
Change
-4.55 (-0.6%)
Open
₹755.1
Prev. Close
₹759.9
Day High
₹767.35
Day Low
₹754.1
Volume Analysis
Traded
818
Delivered
690
Delivery %
84.35%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (2)
- •Below-average fundamentals quality score (43/100)
- •Low operating margin (1.7%)
Opportunities (0)
No signal for this stock
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹777.01 | ₹772.18 | ₹763.76 | ₹758.93 | ₹750.51 | ₹745.68 | ₹737.26 |
| Fibonacci | ₹772.18 | ₹767.12 | ₹763.99 | ₹758.93 | ₹753.87 | ₹750.74 | ₹745.68 |
| Camarilla | ₹758.99 | ₹757.78 | ₹756.56 | ₹758.93 | ₹754.14 | ₹752.92 | ₹751.71 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+2.14%
1 Week
-4.26%
1 Month
-1.76%
3 Months
-12.59%
6 Months
+7.02%
1 Year
-5.73%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
DuPont ROE Breakdown
-0.24%
Net margin -0.3% × asset turnover 0.6x × equity multiplier 1.31x
Company Overview
Sector
Healthcare
Source: Screener.in (Consolidated figures) — data as of 18 Nov 2026. Not investment advice.
TopFund Analysis
Albert David Limited scores weakly on TopFund's composite fundamentals check within the Healthcare sector, at 43/100. The strongest factor is Financial Strength (100/100), while Cash Flow (0/100) is the weakest area to weigh before deciding. Notably: Below-average fundamentals quality score (43/100); low operating margin (1.7%).
TopFund Score — Fundamentals Quality
43/100 — WeakData confidence: 70/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Growth
Cash Flow
Corporate Governance
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Newspaper Publication-Regarding Extract of Unaudited Financial Results for the quarter and half year ended 30th September, 2026
Board approved unaudited Q2 and half-year FY2026 results on November 12, 2026.
Submitted Regulation 74(5) compliance certificate for July 1-September 30, 2026.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Sep 2023 (S) | Dec 2023 (S) | Mar 2024 (S) | Jun 2024 (S) | Sep 2024 (S) | Dec 2024 (S) | Mar 2025 (S) | Jun 2025 (S) | Sep 2025 (S) | Dec 2025 (S) | Mar 2026 (S) | Jun 2026 (S) | Sep 2026 (S) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 93 | 88 | 89 | 89 | 98 | 83 | 75 | 71 | 87 | 90 | 86 | 101 | 101 |
| Expenses + | 77 | 80 | 79 | 88 | 92 | 82 | 80 | 81 | 85 | 79 | 83 | 91 | 89 |
| Operating Profit | 16 | 8 | 10 | 1 | 6 | 1 | -5 | -11 | 3 | 11 | 3 | 11 | 12 |
| OPM % | 17.14% | 9.47% | 10.75% | 0.98% | 6.32% | 0.82% | -6.34% | -15.11% | 2.91% | 12.04% | 3.21% | 10.5% | 11.55% |
| Other Income + | 12 | 17 | 10 | 23 | 21 | -9 | -5 | 22 | -2 | 12 | -25 | 28 | -4 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 |
| Depreciation | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 3 |
| Profit before tax | 27 | 23 | 18 | 22 | 25 | -10 | -12 | 8 | -3 | 20 | -25 | 36 | 5 |
| Tax % | 23.54% | 20.14% | 28.77% | 14.6% | 28.09% | -7.68% | -12.53% | 5.92% | 27.91% | 23.1% | -15.06% | 10.62% | 43.42% |
| Net Profit + | 20 | 19 | 13 | 19 | 18 | -9 | -10 | 8 | -3 | 15 | -21 | 32 | 3 |
| EPS in Rs | 36 | 33 | 23 | 33 | 32 | -16 | -18 | 14 | -6 | 27 | -38 | 56 | 5 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| YoY Sales growth | 1 | 18 | 9 | -3 | 6 | -6 | -16 | -21 | -11 | 8 | 15 | 44 | 16 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 (S) | Mar 2023 (S) | Mar 2024 (S) | Mar 2025 (S) | Mar 2026 (S) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 317 | 318 | 293 | 285 | 316 | 320 | 246 | 313 | 341 | 362 | 345 | 333 |
| Expenses + | 281 | 286 | 266 | 267 | 286 | 289 | 227 | 272 | 297 | 315 | 342 | 327 |
| Operating Profit | 37 | 31 | 27 | 18 | 30 | 30 | 19 | 41 | 44 | 47 | 3 | 6 |
| OPM % | 12.0% | 10.0% | 9.0% | 6.0% | 10.0% | 10.0% | 8.0% | 13.0% | 13.0% | 13.0% | 0.9% | 1.7% |
| Other Income + | 2 | 43 | 8 | 9 | 15 | 7 | 17 | 16 | 15 | 58 | 30 | 7 |
| Interest | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 3 |
| Depreciation | 15 | 9 | 8 | 8 | 7 | 8 | 8 | 9 | 9 | 7 | 7 | 10 |
| Profit before tax | 20 | 63 | 26 | 18 | 38 | 29 | 27 | 47 | 51 | 97 | 25 | 1 |
| Tax % | 32.0% | 24.0% | 39.0% | 45.0% | 29.0% | 34.0% | 19.0% | 25.0% | 29.0% | 22.0% | 32.0% | 379.0% |
| Net Profit + | 14 | 48 | 16 | 10 | 27 | 19 | 22 | 35 | 36 | 75 | 17 | -1 |
| EPS in Rs | 24 | 84 | 28 | 17 | 47 | 34 | 39 | 62 | 63 | 132 | 30 | -3 |
| Dividend Payout % | 23.0% | 7.0% | 20.0% | 32.0% | 13.0% | 21.0% | 15.0% | 15.0% | 14.0% | 9.0% | 17.0% | -192.0% |
| Sales growth | 11 | 0 | -8 | -3 | 11 | 1 | -23 | 27 | 9 | 6 | -5 | -4 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 (S) | Mar 2023 (S) | Mar 2024 (S) | Mar 2025 (S) | Mar 2026 (S) | Sep 2026 (S) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 87 | 131 | 177 | 180 | 205 | 217 | 239 | 274 | 306 | 377 | 387 | 386 | 416 |
| Borrowings + | 30 | 20 | 30 | 28 | 0 | 2 | 2 | 6 | 5 | 3 | 12 | 30 | 34 |
| Other Liabilities + | 71 | 67 | 71 | 76 | 84 | 95 | 95 | 116 | 106 | 112 | 107 | 98 | 98 |
| Total Liabilities | 193 | 224 | 285 | 290 | 295 | 320 | 341 | 401 | 423 | 498 | 511 | 519 | 554 |
| Fixed Assets + | 49 | 44 | 87 | 83 | 77 | 91 | 84 | 88 | 80 | 83 | 99 | 100 | 119 |
| CWIP | 5 | 5 | 9 | 5 | 5 | 2 | 1 | 1 | 3 | 7 | 2 | 21 | 3 |
| Investments | 16 | 48 | 59 | 68 | 113 | 122 | 138 | 183 | 193 | 273 | 260 | 243 | 269 |
| Other Assets + | 122 | 127 | 130 | 134 | 99 | 106 | 119 | 130 | 148 | 135 | 151 | 155 | 162 |
| Total Assets | 193 | 224 | 285 | 290 | 295 | 320 | 341 | 401 | 423 | 498 | 511 | 519 | 554 |
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 (S) | Mar 2023 (S) | Mar 2024 (S) | Mar 2025 (S) | Mar 2026 (S) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 28 | 68 | 20 | 30 | 32 | 30 | 37 | 40 | 11 | 46 | -28 | -8 |
| Cash from Investing Activity + | -9 | -38 | -36 | -11 | -19 | -20 | -37 | -40 | -5 | -33 | 23 | -4 |
| Cash from Financing Activity + | -18 | -18 | 7 | -5 | -17 | -10 | -2 | -2 | -6 | -8 | 0 | 12 |
| Net Cash Flow | 1 | 12 | -10 | 15 | -4 | 0 | -2 | -1 | -1 | 4 | -5 | 0 |
| Free Cash Flow | 18 | 62 | 0 | 31 | 45 | 15 | 35 | 32 | 6 | 35 | -43 | -36 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 95 | 303 | 115 | 204 | 126 | 149 | 202 | 129 | 59 | 131 | -629 | -47 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 35.6% | 35.23% | 35.41% | 35.36% | 35.39% | 35.12% | 35.27% | 35.5% | 35.51% | 35.52% | 35.56% | 35.53% |
| Promoters | 62.04% | 62.13% | 62.13% | 62.13% | 62.13% | 62.23% | 62.23% | 62.23% | 62.23% | 62.23% | 62.23% | 62.23% |
| FII | 0.7% | 0.98% | 0.8% | 0.88% | 0.86% | 1.0% | 0.84% | 0.6% | 0.6% | 0.58% | 0.57% | 0.6% |
| DII | 1.67% | 1.67% | 1.67% | 1.63% | 1.63% | 1.64% | 1.65% | 1.65% | 1.65% | 1.65% | 1.63% | 1.63% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Albert David Limited (this stock) | — | — | — | — |
| Sun Pharmaceutical Ind L | 451,075 | 36.7 | 5.05 | 16.0% |
| Divi S Laboratories Ltd | 294,139 | 86.1 | 16.34 | 16.5% |
| Torrent Pharmaceuticals L | 177,632 | 81.8 | 9.67 | 27.4% |
| Apollo Hospitals Enter. L | 125,893 | 55.6 | 11.86 | 21.5% |
| Laurus Labs Limited | 125,380 | 93.6 | 20.73 | 18.3% |
| Zydus Lifesciences Ltd | 118,693 | 26.2 | 4.27 | 21.2% |
Which Mutual Funds Hold Albert David Limited?
Frequently Asked Questions about Albert David Limited
Albert David Limited (ALBERTDAVD) closed at ₹755.35 on NSE on 19 November 2026, down 4.55 (0.6%) from the previous close.
Albert David Limited trades on the NSE (National Stock Exchange of India) under the symbol ALBERTDAVD.
Albert David Limited has a TopFund Quality Score of 43/100 (Weak), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Albert David Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.